ArticlePharmaceutics2022

Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis.

Sonia Kiran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.